MASI Q3 2024 Earnings — Masimo Corporation Revenue & Financial Results | Market Cap Arena

MASIMasimo Corporation

$9B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$505M+5.4% YoY

Gross Profit

$263M52.2% margin

Operating Income

$30M6.0% margin

Net Income

$10M1.9% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+46.7%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

-$5M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$1.6B

Stockholders' Equity

$1.5B

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$505M	$479M	+5.4%
Gross Profit	$263M	$235M	+12.1%
Operating Income	$30M	$25M	+19.4%
Net Income	$10M	$11M	-7.5%

Revenue Segments

Health Care Segment

$343M100%